BP Specifications and definitions

Slides:



Advertisements
Similar presentations
PERSONALIZED MEDICINE: Planning for the Future You, Your Biomarkers and Your Rights.
Advertisements

INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL Sheree Miller, Pharm.D. University of Washington Medical Center
Chapter 13 Bipolar and Related Disorders Copyright © 2014, 2010, 2006 by Saunders, an imprint of Elsevier Inc.
Pattern of Diabetes Emergencies among adult Yemeni Diabetic Patients Dr. Zayed Atef Faculty of Medicine Sana’a University.
ADVERSE EFFECTS OF DRUGS Phase II May Adverse Drug Reaction An adverse reaction to a drug is a harmful or unintended response. ADRs are claimed.
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
DVT Prevention and Anticoagulant Management
PRINCIPLES OF DRUG ADDICTION TREATMENT Dr. K. S. NJUGUNA.
Definition of Family Medicine General practice / Family Medicine is an academic and scientific discipline, has its own educational content, research, evidence.
Introduction.
100 years of living science Chronic disease management in primary care: lessons to be learnt Dr Shamini Gnani November 2007, Mauritius.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Meet & Greet. Welcome Objectives: 1. Review the core terminology used in pharmacology. 2. Discuss the features of the “perfect” drug. 3. Examine the.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Health care delivery systems Dr. Aidah Alkaissi. Types of health care There are three types of services which:- 1. Health promotion and illness prevention.
B261 Pathophysiology and Pharmacology The study of common diseases and their medication treatments 1.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 3 Drug Regulation, Development, Names, and Information.
(c) 2005 The McGraw-Hill Companies, Inc. All rights reserved. Chapter One: Shaping Your Health.
Acute Kidney Injury. 100,000 deaths are year are associated with acute kidney injury. (NCEPOD 2009)
بسم الله الرحمن الرحيم  الحمد لله رب العالمين والصلاة والسلام علي سيدنا محمد الصادق الوعد الأمين ، اللهم أخرجنا من ظلمات الجهل والوهم ، إلى نور المعرفة.
NUR 231 Pediatric Nursing Laura Salisbury RN, MSN/Ed.
Integrative Approaches to Pharmacotherapy—A Look at Complex Cases
Practical lesson number 1 Theme: "Articular syndrome
Patient Safety in Surgical Care Reducing Patient Harm due to
Dr.Fatima Alkhaledy M.B.Ch.B,F.I.C.M.S/C.M.
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
COMORBIDITY IN ADDICTION AND OTHER MENTAL ILLNESSES
Critical Care Services Pharmacist Royal Manchester Children’s Hospital
Present: Disease Past: Exposure
Paediatric Cardiac Pharmacist Bristol Royal Hospital for Children
Medication Management With Older Adults
بسم الله الرحمن الرحيم الحمد لله رب العالمين والصلاة والسلام علي سيدنا محمد الصادق الوعد الأمين ، اللهم أخرجنا من ظلمات الجهل والوهم ، إلى نور المعرفة.
Chapter 12: Falls in Older Adults
Medication Reconciliation and Reducing Adverse Drug Events
Pharmaceutical Care Plan
Clinical Pharmacy II.
EPAs as Curriculum Tools
Gender Gender refers to the socially constructed characteristics of women and men – such as norms, roles and relationships of and between groups of women.
The Impact of a Structured Balance Training Program on Elderly Adults
Polypharmacy In Adults: Small Test of Change
Syllabus Content Health promotion approaches and strategies
Bonnie Sanderson, PhD, RN
Medication Safety Dr. Kanar Hidayat
Treating Alcohol Abuse
PROMOTING PATIENT SAFETY BY PREVENTING MEDICAL ERRORS
Pharmacovigilance (PV)
Adherence to Medical Regimens
Proposed End of Training EPAs
Using NCACH Project Metrics to determine our Collective Impact
CITE THIS CONTENT: RYAN MURPHY, “EVENT REPORTING”, ACCELERATE UNIVERSITY OF UTAH HEALTH CURRICULUM, JUNE 1, 2018 (Updated August 24, AVAILABLE AT: 
EPA Graphics AFMRD EPA TASK FORCE.
Overview on proposals submitted to first call SC1 - stage 1
Pharmacy practice experience I
Event & Disclosure Reporting
Application of Pharmacology in Nursing Practice
Non-Pharmacological Therapies, Chronic Pain and Opioid Addictions
Non-Drug Ways to Promote Health by Lowering Cholesterol
Background Cancers are among the leading causes of morbidity and mortality worldwide, responsible for 18.1 million new cases and 9.6 million deaths in.
Pharmacy practice and the healthcare system Ola Ali Nassr
What existing research and data can tell us
Medication Safety Dr. Kanar Hidayat
Encouraging care coordination in FFS Medicare
Epidemiological Terms
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Syllabus Content Health promotion approaches and strategies
Copyright © 2013, 2004 by Saunders, an imprint of Elsevier Inc.
The New Zealand Association of Medical Herbalists (NZAMH)
Substance Use Prevention for Young Adults and Higher Education
The Judicial Branch’s Response to the Opioid Crisis
The Chronic Care Model Overview
Presentation transcript:

BP Specifications and definitions Provide an overview pan-Canadian PRA sustainability What needs to be sustained for pan-Canadian PRA Approach & lessons learned

Therapeutics Blueprint and Specifications * Except for Health Promotion and Illness Prevention which is 30% pharmacological and 70% non-pharmacological

Definitions Dimensions of Care Focus of care for the patient, family, community and/or population Health Promotion & Illness Prevention The process of enabling people to increase control over their health and its determinants, and thereby improving their health. Illness prevention covers measures not only to prevent the occurrence of illness such as risk factor reduction but also to arrest its progress and reduce its consequences once established (includes but not limited to screening; periodic health exam; health maintenance; patient education, and advocacy, community and population health) 1. Acute Illness Brief episode of illness within the time span defined by initial presentation through to transition of care. This dimension includes but is not limited to urgent, emergent, and life-threatening conditions, new conditions, and exacerbation of underlying conditions. Chronic Illness Illness of long duration (includes but not limited to slow progression). Safety & Adverse Effects Unintended or harmful effect resulting from a medication or other intervention. Reactions that may occur in anyone or in susceptible subjects 1. World Health Organization, who.int/chp/en, accessed 14/05/2013

Definitions (cont.) Therapeutic Interventions Description Pharmacotherapy Interventions Interventions through introducing chemical substances to the human body. This dimension involves understanding of the different classes of drugs, how they are used therapeutically, their mechanism of action and how they are handled by the human body. Additionally, this dimension involves knowledge of contraindications to the use of chemical substances. Prescribed and non-prescribed medication interventions are included in this dimension. Non- Pharmacotherapy Interventions Therapy that does not involve medication and is beneficial to the health and well being of the patient. (e.g., counseling, exercise, splints).

Definitions (cont.) Constraints Guideline Clinical Topic Sample across family medicine topics as broadly as possible Complexity Multiple morbidities (at least 10%) Age Groups Sample across age groups, including adult women of childbearing age and the frail elderly Gender Balance male and female evenly (with maximum of 40/60% split of either gender)